vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and PROGRESS SOFTWARE CORP (PRGS). Click either name above to swap in a different company.

PROGRESS SOFTWARE CORP is the larger business by last-quarter revenue ($252.7M vs $209.8M, roughly 1.2× MYRIAD GENETICS INC). On growth, PROGRESS SOFTWARE CORP posted the faster year-over-year revenue change (17.5% vs -0.4%). Over the past eight quarters, PROGRESS SOFTWARE CORP's revenue compounded faster (17.0% CAGR vs 1.9%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Progress Software Corporation develops and sells enterprise software products including application development platforms, data connectivity tools, and digital experience solutions. It serves global enterprise clients across finance, healthcare, manufacturing, retail and other sectors, helping organizations build scalable, high-performance business applications and streamline operational workflows.

MYGN vs PRGS — Head-to-Head

Bigger by revenue
PRGS
PRGS
1.2× larger
PRGS
$252.7M
$209.8M
MYGN
Growing faster (revenue YoY)
PRGS
PRGS
+17.9% gap
PRGS
17.5%
-0.4%
MYGN
Faster 2-yr revenue CAGR
PRGS
PRGS
Annualised
PRGS
17.0%
1.9%
MYGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MYGN
MYGN
PRGS
PRGS
Revenue
$209.8M
$252.7M
Net Profit
$25.7M
Gross Margin
70.0%
81.6%
Operating Margin
-2.7%
15.2%
Net Margin
10.2%
Revenue YoY
-0.4%
17.5%
Net Profit YoY
2144.6%
EPS (diluted)
$-0.09
$0.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
PRGS
PRGS
Q4 25
$209.8M
$252.7M
Q3 25
$205.7M
$249.8M
Q2 25
$213.1M
$237.4M
Q1 25
$195.9M
$238.0M
Q4 24
$210.6M
$215.0M
Q3 24
$213.3M
$178.7M
Q2 24
$211.5M
$175.1M
Q1 24
$202.2M
$184.7M
Net Profit
MYGN
MYGN
PRGS
PRGS
Q4 25
$25.7M
Q3 25
$-27.4M
$19.4M
Q2 25
$-330.5M
$17.0M
Q1 25
$-100.0K
$10.9M
Q4 24
$1.1M
Q3 24
$-22.1M
$28.5M
Q2 24
$-36.7M
$16.2M
Q1 24
$-26.0M
$22.6M
Gross Margin
MYGN
MYGN
PRGS
PRGS
Q4 25
70.0%
81.6%
Q3 25
69.9%
81.0%
Q2 25
71.2%
80.1%
Q1 25
68.5%
80.6%
Q4 24
71.7%
83.0%
Q3 24
70.2%
83.7%
Q2 24
69.6%
81.7%
Q1 24
68.1%
82.2%
Operating Margin
MYGN
MYGN
PRGS
PRGS
Q4 25
-2.7%
15.2%
Q3 25
-11.3%
17.6%
Q2 25
-154.5%
16.3%
Q1 25
-14.8%
13.6%
Q4 24
-18.6%
10.0%
Q3 24
-9.4%
22.6%
Q2 24
-17.3%
15.5%
Q1 24
-13.8%
19.0%
Net Margin
MYGN
MYGN
PRGS
PRGS
Q4 25
10.2%
Q3 25
-13.3%
7.8%
Q2 25
-155.1%
7.2%
Q1 25
-0.1%
4.6%
Q4 24
0.5%
Q3 24
-10.4%
15.9%
Q2 24
-17.4%
9.2%
Q1 24
-12.9%
12.3%
EPS (diluted)
MYGN
MYGN
PRGS
PRGS
Q4 25
$-0.09
$0.59
Q3 25
$-0.29
$0.44
Q2 25
$-3.57
$0.39
Q1 25
$0.00
$0.24
Q4 24
$-0.47
$0.01
Q3 24
$-0.24
$0.65
Q2 24
$-0.41
$0.37
Q1 24
$-0.29
$0.51

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
PRGS
PRGS
Cash + ST InvestmentsLiquidity on hand
$149.6M
$94.8M
Total DebtLower is stronger
$119.9M
$1.4B
Stockholders' EquityBook value
$368.0M
$478.3M
Total Assets
$706.6M
$2.5B
Debt / EquityLower = less leverage
0.33×
2.93×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
PRGS
PRGS
Q4 25
$149.6M
$94.8M
Q3 25
$145.4M
$99.0M
Q2 25
$74.4M
$102.0M
Q1 25
$91.8M
$124.2M
Q4 24
$102.4M
$118.1M
Q3 24
$99.9M
$232.7M
Q2 24
$97.3M
$190.4M
Q1 24
$104.3M
$133.2M
Total Debt
MYGN
MYGN
PRGS
PRGS
Q4 25
$119.9M
$1.4B
Q3 25
$119.5M
$1.4B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MYGN
MYGN
PRGS
PRGS
Q4 25
$368.0M
$478.3M
Q3 25
$372.8M
$477.7M
Q2 25
$388.1M
$452.7M
Q1 25
$704.9M
$431.8M
Q4 24
$701.1M
$438.8M
Q3 24
$731.7M
$425.6M
Q2 24
$740.5M
$401.7M
Q1 24
$760.0M
$461.7M
Total Assets
MYGN
MYGN
PRGS
PRGS
Q4 25
$706.6M
$2.5B
Q3 25
$728.1M
$2.4B
Q2 25
$677.3M
$2.4B
Q1 25
$1.0B
$2.5B
Q4 24
$1.0B
$2.5B
Q3 24
$1.1B
$1.6B
Q2 24
$1.1B
$1.6B
Q1 24
$1.1B
$1.5B
Debt / Equity
MYGN
MYGN
PRGS
PRGS
Q4 25
0.33×
2.93×
Q3 25
0.32×
2.97×
Q2 25
3.22×
Q1 25
3.50×
Q4 24
3.48×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
PRGS
PRGS
Operating Cash FlowLast quarter
$10.6M
$62.8M
Free Cash FlowOCF − Capex
$59.9M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
1.1%
Cash ConversionOCF / Net Profit
2.44×
TTM Free Cash FlowTrailing 4 quarters
$229.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
PRGS
PRGS
Q4 25
$10.6M
$62.8M
Q3 25
$21.1M
$73.4M
Q2 25
$-13.6M
$30.0M
Q1 25
$-16.3M
$68.9M
Q4 24
$6.6M
$19.7M
Q3 24
$700.0K
$57.7M
Q2 24
$2.6M
$63.7M
Q1 24
$-18.6M
$70.5M
Free Cash Flow
MYGN
MYGN
PRGS
PRGS
Q4 25
$59.9M
Q3 25
$72.4M
Q2 25
$29.5M
Q1 25
$67.7M
Q4 24
$16.8M
Q3 24
$56.6M
Q2 24
$62.7M
Q1 24
$70.2M
FCF Margin
MYGN
MYGN
PRGS
PRGS
Q4 25
23.7%
Q3 25
29.0%
Q2 25
12.4%
Q1 25
28.4%
Q4 24
7.8%
Q3 24
31.7%
Q2 24
35.8%
Q1 24
38.0%
Capex Intensity
MYGN
MYGN
PRGS
PRGS
Q4 25
1.1%
Q3 25
0.4%
Q2 25
0.2%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.6%
Q2 24
0.5%
Q1 24
0.2%
Cash Conversion
MYGN
MYGN
PRGS
PRGS
Q4 25
2.44×
Q3 25
3.78×
Q2 25
1.76×
Q1 25
6.30×
Q4 24
17.13×
Q3 24
2.03×
Q2 24
3.93×
Q1 24
3.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

PRGS
PRGS

Maintenanceand Services$187.5M74%
Share File Acquisition$67.5M27%

Related Comparisons